Findings from this study of a limited-size sample of under 20 patients with AD, other dementias, neurological disorders, and healthy controls report that the concentrations of ubiquitin were significantly elevated in subjects with AD in comparison to other groups. This evidence concerns the gene UBA52 and nervous system disorder.